Adjunctive ZOL/IL-2 administrations during TB drugs treatment of MDR-TB-infected macaques could significantly increase circulating Vγ2Vδ2 T cells from week 2 through week 14. The gene discussed is IL2; the disease is multidrug-resistant tuberculosis.